Receive The Newest Study Notifications

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

BURLINGAME, Calif., Feb. 01, 2020 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies with biomarker patient...

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

PLYMOUTH MEETING, Pa., Feb. 3, 2020 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of...

CytoDyn Announces Stunning Results from Clinical Trials Evaluating mTNBC and MBC with Leronlimab and will Request an Emergency Type C Meeting with FDA to Enroll 50 Awaiting Patients with a Serious Sol

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Third patient data supports leronlimab (PRO 140) as a potential treatment option for metastatic triple-negative breast cancer (mTNBC) and metastatic breast cancer (MBC). Patient CTC dropped to zero after 2 weeks of leronlimab treatment, same as the first patient on...

Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in Japan by Otsuka Pharmaceutical Co., Ltd. (Otsuka) as part of a May...

RegeneRx Partner Updates on Phase 3 Dry Eye Trial

by Lance Smith | Feb 3, 2020 | Study Scavenger Clinical Trial Recruitment Platform

ROCKVILLE, Md., Feb. 3, 2020 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today...

NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer

by Lance Smith | Jan 30, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Global NuTide:121 Study Is Enrolling up to 828 Patients and Comparing Acelarin plus Cisplatin to Gemcitabine plus Cisplatin NuTide:121 Trials-in-Progress Poster Presented at ASCO-GI   SAN FRANCISCO, Jan. 27, 2020 — NuCana plc (NCNA) announced that the first...